Oregon Clinical and Translational Research Institute

俄勒冈临床和转化研究所

• 批准号: 9514362
• 负责人: David H Ellison
• 金额: $ 616.99万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-02 至 2022-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9514362
• 关键词: Abbreviations; Address; American; Attitude; Award; Big Data to Knowledge; Biological Sciences; Biomedical Research; Biometry; Businesses; Catalysis; Center for Translational Science Activities; Clinic; Clinical; Clinical Research; Clinical Trials; Clinical Trials Design; Collaborations; Communities; Community Networks; Competence; Data; Development; Disease; Ecosystem; Electronic Health Record; Ensure; Environment; Fostering; Funding Opportunities; Future; Goals; Good Clinical Practice; Grant; Health; Health Sciences; Healthcare; Healthcare Systems; Home environment; Human; Individual; Informatics; Institute of Medicine (U.S.); Institutes; Institution; Investigation; Laboratories; Leadership; Link; Malignant Neoplasms; Maps; Medical Informatics; Mentors; Mission; Modeling; Modification; Oregon; Outcome Measure; Pacific Northwest; Patient Recruitments; Patients; Pediatric Hospitals; Performance; Phase; Play; Population; Positioning Attribute; Process; Recruitment Activity; Reporting; Research; Research Design; Research Infrastructure; Research Institute; Research Personnel; Research Project Grants; Resource Sharing; Rural; Science; Scientist; Services; Speed; Statistical Methods; Strategic Planning; Structure; System; Testing; Training; Translating; Translational Research; Universities; Vision; Voice; Work; Workforce Development; bench to bedside; career; career development; clinical care; clinical epidemiology; clinical practice; community building; design; epidemiology study; experience; healing; health information technology; improved; innovation; learning community; member; model development; named group; next generation; novel therapeutics; outreach; practice-based research network; programs; response; skills; success; tool; translational scientist; working group

Contact PD/PI: Ellison, David H. The Oregon Clinical and Translational Research Institute (OCTRI) has been accelerating research at Oregon Health & Science University since 2006. Its many highly functional programs assist investigators and trainees by providing diverse services. Here, we propose that OCTRI will transition to retain our strengths, but also become a key hub in the national network, by focusing on five crosscutting aims. These align closely with the goals of the Funding Opportunity Announcement, and the goals outlined by NCATS for the CTSA program in an ideal state. OCTRI's overall aims are to: Overall Aim 1: Catalyze Clinical and Translational Research. Overall Aim 2: Enhance Partnerships with Communities. Overall Aim 3: Foster and Support Scientific Collaboration. Overall Aim 4: Expand the Translational Workforce for the 21st Century. Overall Aim 5: Cultivate Innovation in Research. We have organized a highly functional leadership structure to enable us to meet these goals, and will seek the guidance of several advisory groups. We will catalyze research by developing and supporting new informatics approaches that both integrate the clinical care enterprise with the research enterprise and facilitate the recruitment of patients into clinical trials, locally and across the CTSA network. We will engage diverse stakeholders in the translational research process, by partnering with OHSU investigators, community coalitions, and business enterprises. We will foster team science through local awards to trainees and to emerging investigators. We will partner with regional institutions to foster community-engaged research, to enhance the diversity of trainees, and to provide opportunities in biomedical research not available at other institutions. We will train clinical and translational scientists and research staff for the next generation, by focusing on the skills and attitudes necessary for research in the future. At all steps, we will measure outcomes and, when necessary, “turn the curve.” Project Summary/Abstract Page 240 Contact PD/PI: Ellison, David H. This proposal is for support of the Oregon Clinical and Translational Research Institute.This institute fosters research to find better treatments for disease and help find ways to keep people healthy. It is also focused on training the translational research workforce of the future.

联系PD/PI：Ellison，大卫H. 俄勒冈州临床和转化研究所（OCTRI）一直在加速俄勒冈州的研究 自2006年以来，健康与科学大学。它的许多功能强大的程序帮助调查人员和学员 提供多样化的服务。在这里，我们建议OCTRI将过渡到保留我们的优势，但也 成为国家网络的一个关键枢纽，侧重于五个跨领域目标。这些与 资助机会公告的目标，以及NCATS为CTSA计划概述的目标， 一个理想的国家。该研究所的总体目标是： 总体目标1：催化临床和转化研究。 总体目标2：加强与社区的伙伴关系。 总体目标3：促进和支持科学合作。 总体目标4：扩大世纪的翻译人才队伍。 总体目标5：培养研究创新。 我们已经组织了一个高度功能化的领导结构，使我们能够实现这些目标，并将寻求 几个咨询小组的指导。我们将通过开发和支持新的信息学来促进研究 将临床护理企业与研究企业相结合， 在本地和整个CTSA网络招募患者参加临床试验。我们将致力于多样化 在转化研究过程中的利益相关者，通过与OHSU研究人员，社区 联盟和商业企业。我们将通过向学员颁发当地奖项， 新兴调查员。我们将与区域机构合作，促进社区参与的研究， 增加受训人员的多样性，并提供其他国家无法提供的生物医学研究机会。 机构职能体系我们将为下一代培养临床和转化科学家和研究人员， 注重未来研究所需的技能和态度。在所有步骤中，我们将衡量结果 在必要的时候，“转弯” 项目摘要/摘要第240页 联系PD/PI：Ellison，大卫H. 本提案是为了支持俄勒冈州临床和转化研究所。该研究所培养 研究以找到更好的治疗疾病的方法，并帮助找到保持人们健康的方法。它还专注于 培养未来的翻译研究队伍。